297 related articles for article (PubMed ID: 34073805)
61. Site-specific conjugation of native antibody.
Sadiki A; Vaidya SR; Abdollahi M; Bhardwaj G; Dolan ME; Turna H; Arora V; Sanjeev A; Robinson TD; Koid A; Amin A; Zhou ZS
Antib Ther; 2020 Dec; 3(4):271-284. PubMed ID: 33644685
[TBL] [Abstract][Full Text] [Related]
62. An enzymatic deconjugation method for the analysis of small molecule active drugs on antibody-drug conjugates.
Li Y; Gu C; Gruenhagen J; Yehl P; Chetwyn NP; Medley CD
MAbs; 2016; 8(4):698-705. PubMed ID: 26891281
[TBL] [Abstract][Full Text] [Related]
63. Conformation and dynamics of interchain cysteine-linked antibody-drug conjugates as revealed by hydrogen/deuterium exchange mass spectrometry.
Pan LY; Salas-Solano O; Valliere-Douglass JF
Anal Chem; 2014 Mar; 86(5):2657-64. PubMed ID: 24512515
[TBL] [Abstract][Full Text] [Related]
64. Characterization of cysteine-linked conjugation profiles of immunoglobulin G1 and immunoglobulin G2 antibody-drug conjugates.
Wiggins B; Liu-Shin L; Yamaguchi H; Ratnaswamy G
J Pharm Sci; 2015 Apr; 104(4):1362-72. PubMed ID: 25631158
[TBL] [Abstract][Full Text] [Related]
65. Antibody structural integrity of site-specific antibody-drug conjugates investigated by hydrogen/deuterium exchange mass spectrometry.
Pan LY; Salas-Solano O; Valliere-Douglass JF
Anal Chem; 2015 Jun; 87(11):5669-76. PubMed ID: 25938577
[TBL] [Abstract][Full Text] [Related]
66. A sensitive multidimensional method for the detection, characterization, and quantification of trace free drug species in antibody-drug conjugate samples using mass spectral detection.
Birdsall RE; McCarthy SM; Janin-Bussat MC; Perez M; Haeuw JF; Chen W; Beck A
MAbs; 2016; 8(2):306-17. PubMed ID: 26651262
[TBL] [Abstract][Full Text] [Related]
67. Utility of Ion Mobility Mass Spectrometry for Drug-to-Antibody Ratio Measurements in Antibody-Drug Conjugates.
Huang RY; Deyanova EG; Passmore D; Rangan V; Deshpande S; Tymiak AA; Chen G
J Am Soc Mass Spectrom; 2015 Oct; 26(10):1791-4. PubMed ID: 26122520
[TBL] [Abstract][Full Text] [Related]
68. Simultaneous monitoring of multiple attributes of pyrrolobenzodiazepine antibody-drug conjugates by size exclusion chromatography - high resolution mass spectrometry.
Füssl F; Barry CS; Pugh KM; Chooi KP; Vijayakrishnan B; Kang GD; von Bulow C; Howard PW; Bones J
J Pharm Biomed Anal; 2021 Oct; 205():114287. PubMed ID: 34385015
[TBL] [Abstract][Full Text] [Related]
69. Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates.
Beck A; Terral G; Debaene F; Wagner-Rousset E; Marcoux J; Janin-Bussat MC; Colas O; Van Dorsselaer A; Cianférani S
Expert Rev Proteomics; 2016; 13(2):157-83. PubMed ID: 26653789
[TBL] [Abstract][Full Text] [Related]
70. A Polar Sulfamide Spacer Significantly Enhances the Manufacturability, Stability, and Therapeutic Index of Antibody-Drug Conjugates.
Verkade JMM; Wijdeven MA; Van Geel R; Janssen BMG; Van Berkel SS; Van Delft FL
Antibodies (Basel); 2018 Feb; 7(1):. PubMed ID: 31544864
[TBL] [Abstract][Full Text] [Related]
71. An Online Four-Dimensional HIC×SEC-IM×MS Methodology for Proof-of-Concept Characterization of Antibody Drug Conjugates.
Ehkirch A; D'Atri V; Rouviere F; Hernandez-Alba O; Goyon A; Colas O; Sarrut M; Beck A; Guillarme D; Heinisch S; Cianferani S
Anal Chem; 2018 Feb; 90(3):1578-1586. PubMed ID: 29260862
[TBL] [Abstract][Full Text] [Related]
72. Site-specific and hydrophilic ADCs through disulfide-bridged linker and branched PEG.
Shao S; Tsai MH; Lu J; Yu T; Jin J; Xiao D; Jiang H; Han M; Wang M; Wang J
Bioorg Med Chem Lett; 2018 May; 28(8):1363-1370. PubMed ID: 29559276
[TBL] [Abstract][Full Text] [Related]
73. Pyrrolobenzodiazepine Antibody-Drug Conjugates Designed for Stable Thiol Conjugation.
Christie RJ; Tiberghien AC; Du Q; Bezabeh B; Fleming R; Shannon A; Mao S; Breen S; Zhang J; Zhong H; Harper J; Wu H; Howard PW; Gao C
Antibodies (Basel); 2017 Nov; 6(4):. PubMed ID: 31548535
[TBL] [Abstract][Full Text] [Related]
74. Qualitative analysis of antibody-drug conjugates (ADCs): an experimental comparison of analytical techniques of cysteine-linked ADCs.
Källsten M; Hartmann R; Artemenko K; Lind SB; Lehmann F; Bergquist J
Analyst; 2018 Nov; 143(22):5487-5496. PubMed ID: 30289422
[TBL] [Abstract][Full Text] [Related]
75. Engineered cysteine antibodies: an improved antibody-drug conjugate platform with a novel mechanism of drug-linker stability.
Sussman D; Westendorf L; Meyer DW; Leiske CI; Anderson M; Okeley NM; Alley SC; Lyon R; Sanderson RJ; Carter PJ; Benjamin DR
Protein Eng Des Sel; 2018 Feb; 31(2):47-54. PubMed ID: 29370435
[TBL] [Abstract][Full Text] [Related]
76. Photoinduced aggregation of a model antibody-drug conjugate.
Cockrell GM; Wolfe MS; Wolfe JL; Schöneich C
Mol Pharm; 2015 Jun; 12(6):1784-97. PubMed ID: 25880156
[TBL] [Abstract][Full Text] [Related]
77. Collision-Induced Unfolding Reveals Stability Differences in Infliximab Therapeutics under Native and Heat Stress Conditions.
Vallejo DD; Kang J; Coghlan J; Ramírez CR; Polasky DA; Kurulugama RT; Fjeldsted JC; Schwendeman AA; Ruotolo BT
Anal Chem; 2021 Dec; 93(48):16166-16174. PubMed ID: 34808055
[TBL] [Abstract][Full Text] [Related]
78. Middle-Down Multi-Attribute Analysis of Antibody-Drug Conjugates with Electron Transfer Dissociation.
Chen B; Lin Z; Zhu Y; Jin Y; Larson E; Xu Q; Fu C; Zhang Z; Zhang Q; Pritts WA; Ge Y
Anal Chem; 2019 Sep; 91(18):11661-11669. PubMed ID: 31442030
[TBL] [Abstract][Full Text] [Related]
79. Characterization of Ring-Opening Reaction of Succinimide Linkers in ADCs.
Zheng K; Chen Y; Wang J; Zheng L; Hutchinson M; Persson J; Ji J
J Pharm Sci; 2019 Jan; 108(1):133-141. PubMed ID: 30458165
[TBL] [Abstract][Full Text] [Related]
80. Characterization of Antibody-Drug Conjugate Pharmacokinetics and in Vivo Biotransformation Using Quantitative Intact LC-HRMS and Surrogate Analyte LC-MRM.
Huang Y; Mou S; Wang Y; Mu R; Liang M; Rosenbaum AI
Anal Chem; 2021 Apr; 93(15):6135-6144. PubMed ID: 33835773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
